Performant Healthcare, Inc. logo PHLT - Performant Healthcare, Inc.

Inactive Ticker PHLT is not actively trading. Quotes and analytics may be stale.
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 1
HOLD 1
SELL 0
STRONG
SELL 0
| PRICE TARGET: $7.75 DETAILS
HIGH: $7.75
LOW: $7.75
MEDIAN: $7.75
CONSENSUS: $7.75
UPSIDE: 0.00%
Annual Quarterly
Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Revenue
Revenue 123.0 113.7 109.2 124.4 155.9 150.4 155.7 132.0 141.4 159.4 195.4 255.3 210.1 163.0 123.5
Cost of Revenue 0 0 0 125.1 100.7 115.2 96.1 82.2 78.9 88.1 93.7 96.8 83.0 0 58.1
Gross Profit 123.0 113.7 109.2 124.4 55.3 35.2 59.5 49.9 62.5 71.3 101.7 158.5 127.1 163.0 65.4
Operating Expenses
R&D Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SG&A Expenses 100.4 90.4 85.3 87.4 100.7 115.2 96.1 82.2 78.9 88.1 93.7 96.8 83.0 67.1 58.1
Other Expenses 32.0 29.4 30.8 38.3 (31.4) (60.3) (34.8) (25.2) (8.4) (23.5) (19.2) (11.1) (11.7) 62.6 (24.5)
Operating Expenses 132.5 119.9 116.1 125.7 69.2 54.9 61.3 56.9 70.4 64.6 74.4 85.7 71.3 129.7 33.7
Operating Income
Operating Income (9.5) (6.1) (6.9) (1.3) (14.0) (19.6) (1.8) (7.1) (7.9) 6.7 27.3 72.9 55.8 33.3 31.8
Interest Expense 1.1 2.0 1.0 11.3 7.2 7.6 4.7 7.0 7.9 8.9 10.2 11.6 12.4 13.5 15.2
Interest Income 0.4 0.2 0 0 0.0 0.0 0.0 0.0 0 0 0.0 0.0 0.1 0.1 0.1
Profitability
EBITDA (2.2) 0.8 0.3 8.1 (6.9) (8.5) 8.5 3.8 5.5 19.8 39.7 83.5 61.7 41.2 39.1
EBIT (9.1) (5.9) (5.4) 1.1 (13.9) (19.6) (1.8) (7.1) (7.9) 6.7 27.3 72.9 52.2 33.4 31.9
Income Before Tax (10.2) (7.9) (6.4) (10.2) (21.2) (27.2) (6.5) (14.1) (15.8) (2.2) 17.1 61.3 39.7 19.9 16.6
Income Tax Expense (0.4) (0.3) 0.1 0.1 (7.2) (0.4) 1.5 (1.3) (4.4) (0.4) 7.7 25.0 16.8 7.5 6.7
Net Income (9.9) (7.5) (6.5) (10.3) (14.0) (26.8) (8.0) (12.7) (11.5) (1.8) 9.4 36.3 23.0 12.4 10.0
Per Share Data
EPS (Basic) -0.13 -0.10 -0.09 -0.17 -0.26 -0.50 -0.15 -0.25 -0.23 -0.04 0.19 0.77 0.48 0.13 0.09
EPS (Diluted) -0.13 -0.10 -0.09 -0.17 -0.26 -0.50 -0.15 -0.25 -0.23 -0.04 0.19 0.74 0.44 0.13 0.09
Shares Outstanding 77.5 76.2 72.9 60.5 54.4 53.5 52.1 50.7 50.0 49.4 48.8 47.5 44.0 45.1 45.1
Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Current Assets
Cash & Cash Equivalents 9.3 7.3 23.4 17.3 16.0 3.4 5.5 21.7 33.0 71.2
Short-Term Investments 0 0 0 0 0 0 0 0 0 0
Net Receivables 25.1 28.8 30.4 32.1 32.4 28.7 21.1 19.3 13.5 18.0
Inventory 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0.6 3.7 3.7 2.2 2.3 1.6 1.8 1.8 12.8 7.2
Total Current Assets 38.4 39.8 57.5 54.7 54.5 37.0 31.8 55.5 72.0 109.2
Non-Current Assets
Property, Plant & Equipment 14.8 10.3 13.0 18.9 22.5 25.6 22.3 20.9 23.7 25.5
Goodwill 47.4 47.4 47.4 47.4 47.4 74.4 81.6 81.6 82.5 82.5
Intangible Assets 0 0 0 0 0.7 0.9 1.2 4.9 5.9 25.1
Long-Term Investments 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 1.2 1.6 1 1.0 1.1 1.0 1.0 1.1 0.9 0.2
Total Non-Current Assets 63.4 59.2 61.3 67.3 71.7 101.9 106.0 108.9 113.1 133.3
Total Assets 101.8 99.0 118.8 122.0 126.2 138.9 137.8 164.4 185.1 242.5
Current Liabilities
Account Payables 0.5 0.7 1.3 1.1 0.4 2.5 1.4 1.5 0.6 0.9
Short-Term Debt 0.4 0.2 1.0 0.5 60.0 3.3 2.2 2.0 9.7 8.0
Deferred Revenue 0.8 0.5 0.4 0.6 0.9 0.1 1.1 0 0 0
Other Current Liabilities 3.5 2.7 3.4 4.9 4.9 4.6 3.6 22.2 23.7 24.7
Total Current Liabilities 14.0 12.4 14.2 17.5 77.2 19.4 14.1 43.1 51.5 53.7
Non-Current Liabilities
Long-Term Debt 8 5 18.2 19.1 0 58.6 41.1 38.6 43.9 84.1
Deferred Tax Liabilities 0 0 0 0 0 0.0 0.0 0 1.1 8.8
Other Non-Current Liabilities 2.8 0.6 0.9 1.2 3.6 2.2 5.3 2.5 2.4 2.0
Total Non-Current Liabilities 11.3 5.9 20.1 22.1 7.0 65.8 46.4 41.0 47.4 95.0
Total Liabilities 25.3 18.3 34.3 39.6 84.2 85.2 60.5 84.1 98.8 148.7
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (75.2) (65.3) (57.8) (51.2) (41.0) (27.0) (0.1) 7.9 20.6 32.0
Accumulated Other Comprehensive Income 0 0 0 0 0 0 0 0 0 0
Total Stockholders' Equity 76.5 80.7 84.5 82.4 42.0 53.6 77.2 80.3 86.2 93.9
Total Liabilities & Equity 101.8 99.0 118.8 122.0 126.2 138.9 137.8 164.4 185.1 242.5
Debt Metrics
Total Debt 8.8 5.5 21.5 23.2 65.7 69.6 43.3 40.6 53.6 92.1
Net Debt (0.4) (1.7) (1.9) 5.9 49.7 66.3 37.9 18.9 20.6 21.0
Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Operating Activities
Net Income (9.9) (7.5) (6.5) (10.3) (14.0) (26.8) (8.0) (12.7) (11.5) (1.8)
Depreciation & Amortization 6.9 6.7 5.7 7.0 7.0 11.1 10.2 10.9 13.4 13.1
Stock-Based Compensation 5.9 3.9 3.0 2.6 2.6 2.3 2.8 3.7 4.7 5.0
Change in Working Capital 3.0 (0.3) (3.7) (3.7) (3.0) (9.2) (2.2) (6.5) 0.9 1.9
Other Non-Cash Items 0.3 1.0 (1.4) 5.3 28.2 7.2 (15.4) 3.9 17.2 0.9
Operating Cash Flow 6.2 3.9 (2.9) 0.9 20.8 (15.4) (12.1) 3.0 17.8 16.2
Investing Activities
Capital Expenditure (7.0) (4.1) (3.6) (3.4) (3.8) (4.9) (7.6) (7.3) (7.9) (7.9)
Acquisitions 0 0 0 0 0 0 2.3 0 0 0
Purchases of Investments 0 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0.0 5.3 3.1 0 0 0 0 0 1.3
Investing Cash Flow (7.0) (4.1) 1.7 (0.3) (3.8) (4.9) (5.4) (7.3) (7.9) (6.6)
Financing Activities
Net Debt Issuance 3 (14.5) (0.5) (40.9) (3.5) 18.5 1.8 (11.5) (39.1) (17.5)
Stock Repurchased 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (0.2) (1.4) (0.0) (1.2) (0.3) (0.5) (0.5) (1.2) (1.6) (1.2)
Financing Cash Flow 2.8 (15.9) 5.1 0.6 (3.7) 18.0 1.3 (12.7) (40.6) (18.7)
Cash Position
Net Change in Cash 2.0 (16.1) 3.9 1.3 13.3 (2.3) (16.2) (17.0) (30.7) (9.1)
Cash at Beginning 7.3 23.5 19.6 18.3 5.0 7.3 23.5 40.5 71.2 80.3
Cash at End 9.3 7.3 23.5 19.6 18.3 5.0 7.3 23.5 40.5 71.2
Free Cash Flow (0.8) (0.3) (6.5) (2.5) 17.0 (20.3) (19.8) (4.3) 9.9 8.3
Key Metrics 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Income Statement
Revenue 123.0 113.7 109.2 124.4 155.9 150.4 155.7 132.0 141.4 159.4 195.4 255.3 210.1 163.0 123.5
Gross Profit 123.0 113.7 109.2 124.4 55.3 35.2 59.5 49.9 62.5 71.3 101.7 158.5 127.1 163.0 65.4
Operating Income (9.5) (6.1) (6.9) (1.3) (14.0) (19.6) (1.8) (7.1) (7.9) 6.7 27.3 72.9 55.8 33.3 31.8
Net Income (9.9) (7.5) (6.5) (10.3) (14.0) (26.8) (8.0) (12.7) (11.5) (1.8) 9.4 36.3 23.0 12.4 10.0
EPS (Diluted) -0.13 -0.10 -0.09 -0.17 -0.26 -0.50 -0.15 -0.25 -0.23 -0.04 0.19 0.74 0.44 0.13 0.09
Balance Sheet
Cash & Equivalents 9.3 7.3 23.4 17.3 16.0 3.4 5.5 21.7 33.0 71.2
Total Assets 101.8 99.0 118.8 122.0 126.2 138.9 137.8 164.4 185.1 242.5
Total Debt 8.8 5.5 21.5 23.2 65.7 69.6 43.3 40.6 53.6 92.1
Stockholders' Equity 76.5 80.7 84.5 82.4 42.0 53.6 77.2 80.3 86.2 93.9
Cash Flow
Operating Cash Flow 6.2 3.9 (2.9) 0.9 20.8 (15.4) (12.1) 3.0 17.8 16.2
Capital Expenditure (7.0) (4.1) (3.6) (3.4) (3.8) (4.9) (7.6) (7.3) (7.9) (7.9)
Free Cash Flow (0.8) (0.3) (6.5) (2.5) 17.0 (20.3) (19.8) (4.3) 9.9 8.3